Recurrent implantation failure (RIF) may be observed in some young women with polycystic ovary syndrome (PCOS) after in-vitro fertilization (IVF) [1]. The observation that administration of growth hormone (GH) during ovarian stimulation may improve IVF outcomes, not only in women aged >40 years [2] but also in younger women with RIF [3], led us to consider the use of GH therapy in women with RIF, independently of their age.
Effect of growth hormone administration on ICSI outcomes in patients with polycystic ovary syndrome and recurrent implantation failure: A retrospective cross-over study
Vitale, Salvatore Giovanni;Palumbo, Marco;
2021-01-01
Abstract
Recurrent implantation failure (RIF) may be observed in some young women with polycystic ovary syndrome (PCOS) after in-vitro fertilization (IVF) [1]. The observation that administration of growth hormone (GH) during ovarian stimulation may improve IVF outcomes, not only in women aged >40 years [2] but also in younger women with RIF [3], led us to consider the use of GH therapy in women with RIF, independently of their age.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Effect of growth hormone administration on ICSI outcomes.pdf
solo gestori archivio
Tipologia:
Versione Editoriale (PDF)
Licenza:
NON PUBBLICO - Accesso privato/ristretto
Dimensione
272.56 kB
Formato
Adobe PDF
|
272.56 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
